The Changing Landscape of Breast Cancer: How Biology Drives Therapy

The Changing Landscape of Breast Cancer: How Biology Drives Therapy

Breast cancer is the most prevalent life-threatening cancer in women. Optimizing therapy to increase cure rates in early stage disease, and improving life expectancy and palliation for advanced stages, are goals driving major areas of research. The armamentarium of targeted treatments for breast can...

Full description

Bibliographic Details
Main Authors: Sarah Friend, Melanie Royce
Format: Article
Language:English
Published: MDPI AG 2016-01-01
Series:Medicines
Subjects:
breast cancer
targeted therapy
PI3K/AKT/mTOR Inhibitors
cyclin-dependent kinase (CDK) inhibitors
pertuzumab
Ado-trastruzumab-emtansine
angiogenesis inhibitors
poly (ADP-ribose) polymerases (PARP) inhibitors
Online Access:http://www.mdpi.com/2305-6320/3/1/2

Internet

http://www.mdpi.com/2305-6320/3/1/2

Similar Items